Nektar Therapeutics Reports Financial Results for the First Quarter of 2018
Go back to Nektar Therapeutics Reports Financial Results for the First Quarter of 2018| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 65.22 +4.24 (6.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.98 | 52 Week High | $19.98 | |||
| Open | $62.30 | 52 Week Low | $10.52 | |||
| Day High | $66.60 | P/E | N/A | |||
| Day Low | $62.30 | EPS | $-1.45 | |||
| Volume | 446,197 | |||||
